LIBERTAS: A Degendered and Transgender-Inclusive Phase 3 Study of Apalutamide (APA) Plus Intermittent Vs Continuous Androgen Deprivation Therapy (ADT) in Participants (pts) with Metastatic Hormone-Sensitive Prostate Cancer (Mhspc).
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要